Evidence map›Paper›PMID 34019141›Full record

ReviewSeminars in immunopathology2021

Regulation of eosinophil functions by autophagy.

Nina Germic, Aref Hosseini, Shida Yousefi, Alexander Karaulov, Hans-Uwe Simon

Open access · hybridAbstract readReview
In one paragraph

Review in Seminars in immunopathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Aerosol Inhalation of Heat-KilledJournal of immunology research · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. The Enigma of Eosinophil Degranulation.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Nina GermicInstitute of Pharmacology, University of Bern, Inselspital, INO-F, 3010, Bern, Switzerland.
Aref HosseiniInstitute of Pharmacology, University of Bern, Inselspital, INO-F, 3010, Bern, Switzerland.
Shida YousefiInstitute of Pharmacology, University of Bern, Inselspital, INO-F, 3010, Bern, Switzerland.
Alexander KaraulovDepartment of Clinical Immunology and Allergology, Sechenov University, 119991, Moscow, Russia.
Hans-Uwe SimonInstitute of Pharmacology, University of Bern, Inselspital, INO-F, 3010, Bern, Switzerland. hus@pki.unibe.ch.ORCID 0000-0002-9404-7736
University of Bern · CHSechenov University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eosinophils are granule-containing leukocytes which develop in the bone marrow. For many years, eosinophils have been recognized as cytotoxic effector cells, but recent studies suggest that they perform additional immunomodulatory and homeostatic functions. Autophagy is a conserved intracellular process which preserves cellular homeostasis. Autophagy defects have been linked to the pathogenesis of many human disorders. Evidence for abnormal regulation of autophagy, including decreased or increased expression of autophagy-related (ATG) proteins, has been reported in several eosinophilic inflammatory disorders, such as Crohn's disease, bronchial asthma, eosinophilic esophagitis, and chronic rhinosinusitis. Despite the increasing extent of research using preclinical models of immune cell-specific autophagy deficiency, the physiological relevance of autophagic pathway in eosinophils has remained unknown until recently. Owing to the increasing evidence that eosinophils play a role in keeping organismal homeostasis, the regulation of eosinophil functions is of considerable interest. Here, we discuss the most recent advances on the role of autophagy in eosinophils, placing particular emphasis on insights obtained in mouse models of infections and malignant diseases in which autophagy has genetically dismantled in the eosinophil lineage. These studies pointed to the possibility that autophagy-deficient eosinophils exaggerate inflammation. Therefore, the pharmacological modulation of the autophagic pathway in these cells could be used for therapeutic interventions.

Indexed as

AsthmaEosinophilsAutophagyHomeostasisHumansInflammationAutophagyDegranulationDifferentiationEosinophilEosinophilic diseaseEosinophilic leukemia

Identifiers

PMID34019141
PMCPMC8241657
OpenAlexW3160179608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.